PET mapping of extrastriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and [11C]FLB 457

NeuroImage

Volumn 10, Issue 6, 1999, Pages 666-674

  Okubo, Yoshiro ^a,b   Olsson, Hans ^a   Ito, Hiroshi ^a   Lofti, Mirijam ^a   Suhara, Tetsuya ^c   Halldin, Christer ^a   Farde, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NONE

Author keywords

Anatomic standardization; D2 dopamine receptors; Human brain; Positron emission tomography; 11C FLB 457

Indexed keywords

CARBON 11; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ISOREMOXIPRIDE; RACLOPRIDE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BASAL GANGLION; BRAIN MAPPING; CAUDATE NUCLEUS; CINGULATE GYRUS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; FRONTAL CORTEX; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS; MALE; NEUROANATOMY; NORMAL HUMAN; NUCLEUS ACCUMBENS; PARIETAL LOBE; PRIORITY JOURNAL; PUTAMEN; RECEPTOR AFFINITY; RECEPTOR DENSITY; RED NUCLEUS; SCHIZOPHRENIA; STANDARDIZATION; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TEMPORAL CORTEX; THALAMUS;

EID: 0033378521     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.1999.0502     Document Type: Article

References (39)

1. Alexander G. E., DeLong M. R., Strick P. L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9:1986;357-381.
2. Anden N., Stock G. Effect of colozapine on the turnover of dopamine in the corpus striatum and the limbic system. J. Pharmacol. 25:1973;346.
3. Bohm C., Greitz T., Blomqvist G., Farde L., Forsgren P. O., Kingsley D., Sjogren I., Wiesel F., Wik G. Applications of a computerized adjustable brain atlas in positron emission tomography. Acta Radiologica. 369:1986;449-452.
4. Carlsson M., Carlsson A. Schizophrenia: A subcortical neurotransmitter imbalance syndrome. Schizophr. Bull. 16:1990;425-432.
5. Farde L., Ehrin E., Eriksson L., Greitz T., Hall H., Hedstrom C. G., Litton J. E., Sedvall G. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proc. Natl. Acad. Sci. USA. 82:1985;3863-3867.
6. Farde L., Hall H., Ehrin E., Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science. 231:1986;258-261.
7. 11C] raclopride binding to D2-dopamine receptors studied by PET - A comparison to the equilibrium analysis. J. Cereb. Blood Flow Metab. 9:1989;696-708.
8. 11C]raclopride. Arch. Gen. Psychiatry. 47:1990;213-219.
9. 11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology. 133:1997;396-404.
10. Fox P. T., Mintun M. A., Reiman E. M., Raichle M. E. Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J. Cereb. Blood Flow Metab. 8:1988;642-653.
11. Goldsmith S. K., Shapiro R. M., Joyce J. N. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study. Arch. Gen. Psychiatry. 54:1997;649-658.
12. Greitz T., Bohm C., Holte S., Eriksson L. A computerized brain atlas: Construction, anatomical content, and some applications. J. Comput. Assisted Tomogr. 15:1991;26-38.
13. 3H-raclopride. J. Neural Transm. 73:1988;7-21.
14. 125I]epidepride. Synapse. 23:1996;115-123.
15. Halldin C., Farde L., Hogberg T., Hall H., Strom P., Ohlberger A., Solin O. A comparative PET-study of five carbon-11 or fluorine-18 labelled salicylamides. Preparation and in vitro dopamine D-2 receptor binding. Int. J. Rad. Appl. Instr. B, Nucl. Med. Biol. 18:1991;871-881.
16. Halldin C., Farde L., Hogberg T., Mohell N., Hall H., Suhara T., Karlsson P., Nakashima Y., Swahn C. G. Carbon-11-FLB 457: A radioligand for extrastriatal D2 dopamine receptors. J. Nucl. Med. 36:1995;1275-1281.
17. Heckers S. Neuropathology of schizophrenia - cortex, thalamus, basal ganglia, and neurotransmitter-specific projection system. Schizophr. Bull. 23:1997;403-421.
18. 11C]raclopride: PET with anatomic standardization technique. NeuroImage. 9:1999;235-242.
19. Janowsky A., Neve K. A., Kinzie J. M., Taylor B., de P. T., Belknap J. K. Extrastriatal dopamine D2 receptors: Distribution, pharmacological characterization and region-specific regulation by clozapine. J. Pharmacol. Exp. Ther. 261:1992;1282-1290.
20. Jones E. G. Cortical development and thalamic pathology in schizophrenia. Schizophr. Bull. 23:1997;483-501.
21. 125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. J. Pharmacol. Exp. Ther. 257:1991;1253-1263.
22. Kerwin R. W., Murray R. M. A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia. Schizophr. Res. 7:1992;1-12.
23. 125I]epidepride. Brain Res. 609:1993;237-243.
24. Landwehrmeyer B., Mengod G., Palacios J. M. Dopamine D3 receptor mRNA and binding sites in human brain. Mol. Brain Res. 18:1993;187-192.
25. 125I]iodosulpride, a highly selective ligand. Science. 228:1985;752-755.
26. Murray A. M., Ryoo H. L., Gurevich E., Joyce J. N. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc. Natl. Acad. Sci. USA. 91:1994;11271-11275.
27. 11C]N-methylspiperone. Psych. Res. Neuroim. 61:1995;67-83.
28. Okubo Y., Suhara T., Suzuki K., Kobayashi K., Inoue O., Terasaki O., Someya Y., Sassa T., Sudo Y., Matsushima E., Iyo M., Tateno Y., Toru M. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 385:1997;634-636.
29. 11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain, J. Nucl. Med.
30. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch. Gen. Psychiatry. 47:1990;1023-1028.
31. Pilowsky L. S., Mulligan R. S., Acton P. D., Ell P. J., Costa D. C., Kerwin R. W. Limbic selectivity of clozapine. Lancet. 350:1997;490-491.
32. Seitz R. J., Bohm C., Greitz T., Roland P. E., Eriksson L., Blomqvist G., Rosenqvist G., Nordell B. Accuracy and precision of the computerized brain atlas programme for localization and quantification in positron emission tomography. J. Cereb. Blood Flow Metab. 10:1990;443-457.
33. Shapiro R. M. Regional neuropathology in schizophrenia: Where are we. Schizophr. Res. 10:1993;187-239.
34. Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., Schwartz J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. 347:1990;146-151.
35. Stevens J. R. Psychosis and the temporal lobe. Adv. Neurol. 55:1991;79-96.
36. Suhara T., Sudo Y., Okauchi T., Maeda J., Kawabe K., Suzuki K., Okubo Y., Nakashima Y., Ito H., Tanada S., Halldin C., Farde L. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. Int. J. Neuropsychopharmacol. 2:1999;73-82.
37. Thurfjell, L., Bohm, C., Greitz, T., Eriksson, L., and Ingvar, M.1994. Accuracy and precision in image standardization in intra- and intersubject comparisons. In Functional NeuroimagingE. K. Roger, Eds., pp. 121-130. Futura, New York.
38. Wagner H. J., Burns H. D., Dannals R. F., Wong D. F., Langstrom B., Duelfer T., Frost J. J., Ravert H. T., Links J. M., Rosenbloom S. B., Lukas S. E., Kramer A. V., Kuhar M. J. Imaging dopamine receptors in the human brain by positron tomography. Science. 221:1983;1264-1266.
39. Watson, C. C., Newport, D., and Casey, M. E.1996. A single scatter simulation technique for scatter correction in 3D PET. In Three-Dimensional Image Reconstruction in Radiology and Nuclear MedicineP. Grangeat and J. L. Amans, Eds., pp. 255-268. Kluwer Academic, Dordrecht, The Netherlands.